Sawaya Rana M, Riddick David S
Department of Pharmacology & Toxicology, Medical Sciences Building, University of Toronto, Toronto, Ontario, Canada M5S 1A8.
Toxicology. 2008 Jun 27;248(2-3):104-12. doi: 10.1016/j.tox.2008.03.011. Epub 2008 Mar 22.
Aromatic hydrocarbons elicit toxic and adaptive responses via the aryl hydrocarbon receptor (AHR). Aromatic hydrocarbons suppress the transcription of the growth hormone-regulated, male-specific rat hepatic cytochrome P450 2C11 gene (CYP2C11) in vivo via an unknown mechanism. We hypothesize that the suppression of CYP2C11 by aromatic hydrocarbons is mediated by the gene's promoter and 5'-flanking region. Following bioinformatic analysis of putative transcription factor (TF) binding sites, we cloned extended lengths of the CYP2C11 5'-flanking region into a promoterless luciferase plasmid. Suppression of CYP2C11 constructs was not observed upon treatment of transfected rat 5L, BP8 or mouse Hepa-1 cells with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) or 3-methylcholanthrene. In human HepG2 cells, the 10.1-kb construct displayed a pronounced 6- to 8-fold induction by TCDD. Deletion analysis localized the paradoxical induction response to a region between -1.8 kb and -1.3 kb, which contains a dioxin-responsive element (DRE) previously shown by us to be capable of binding activated AHR. This was confirmed by site-directed mutagenesis of the DRE. Induction of the 10.1-kb construct by TCDD in HepG2 cells was blocked by alpha-naphthoflavone, an AHR antagonist/partial agonist. The AHR is likely involved in the induction of CYP2C11-luciferase activity by TCDD in HepG2 cells and this response is at least partly DRE-mediated. Although CYP2C11 is suppressed by aromatic hydrocarbons in vivo, CYP2C11-luciferase constructs display a potentially misleading paradoxical induction in vitro that is cell-specific. Regulation of CYP2C11-luciferase plasmids is being studied in vivo in rat liver, where an intact endocrine system and the full complement of TFs needed for CYP2C11 suppression are present.
芳香烃通过芳烃受体(AHR)引发毒性和适应性反应。芳香烃在体内通过未知机制抑制生长激素调节的雄性特异性大鼠肝脏细胞色素P450 2C11基因(CYP2C11)的转录。我们推测芳香烃对CYP2C11的抑制作用是由该基因的启动子和5'侧翼区域介导的。在对假定的转录因子(TF)结合位点进行生物信息学分析后,我们将CYP2C11 5'侧翼区域的延长片段克隆到无启动子的荧光素酶质粒中。用2,3,7,8-四氯二苯并对二恶英(TCDD)或3-甲基胆蒽处理转染的大鼠5L、BP8或小鼠Hepa-1细胞后,未观察到CYP2C11构建体的抑制作用。在人HepG2细胞中,10.1 kb的构建体显示出TCDD明显的6至8倍诱导。缺失分析将这种矛盾的诱导反应定位到-1.8 kb和-1.3 kb之间的区域,该区域包含一个二恶英反应元件(DRE),我们之前已证明其能够结合活化的AHR。通过对DRE进行定点诱变证实了这一点。HepG2细胞中TCDD对10.1 kb构建体的诱导作用被AHR拮抗剂/部分激动剂α-萘黄酮阻断。AHR可能参与了HepG2细胞中TCDD对CYP2C11-荧光素酶活性的诱导,并且这种反应至少部分是由DRE介导的。尽管CYP2C11在体内被芳香烃抑制,但CYP2C11-荧光素酶构建体在体外显示出潜在的误导性矛盾诱导,这是细胞特异性的。正在大鼠肝脏中对CYP2C11-荧光素酶质粒的调控进行体内研究,大鼠肝脏中存在完整的内分泌系统和CYP2C11抑制所需的全部转录因子。